| Literature DB >> 12525263 |
Theodore A Myatt1, Sebastian L Johnston, Stephen Rudnick, Donald K Milton.
Abstract
BACKGROUND: Rhinovirus, the most common cause of upper respiratory tract infections, has been implicated in asthma exacerbations and possibly asthma deaths. Although the method of transmission of rhinoviruses is disputed, several studies have demonstrated that aerosol transmission is a likely method of transmission among adults. As a first step in studies of possible airborne rhinovirus transmission, we developed methods to detect aerosolized rhinovirus by extending existing technology for detecting infectious agents in nasal specimens.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12525263 PMCID: PMC140314 DOI: 10.1186/1471-2458-3-5
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Figure 1Schematic diagram of the experimental chamber. a: Teflon filter; b: manifold; c: baffles; d: UV fixture; e: UV exposure chamber; f: sampling slide; g: air valve; h: port with the same features as the port below; i: drying jar; j: Collison nebulizer; k: pressure regulator; l: air valve; m: vacuum pump; n: rotameter; o: temperature and RH sensor
Figure 2PCR analysis of experimental contaminated air samples from VA Run 13 Lane 1: Marker; Lane 2:Nebulizer solution before run; Lane 3: Nebulizer solution after run; Lane 4: Filter sample; Lane 5: Filter sample; Lane 6: Spiked filter; Lane 7: Filter sample; Lane 8: Blank filter; Lane 9: Positive control; Lane 10: Negative control.
Detection of Experimental Rhinovirus 16 Aerosols by Semi-nested RT-PCR of Filter Samples
| Nebulizing Solution | ||||||
| Run Number | TCID50 per ml | Total ml Nebulized | Fractional Sampling Time per Filtera | Yieldb | Predicted TCID50 per Filterc | Positive Filters/Total |
| VA Run 12 | 16.1 | 15.2 | 0.136 | 0.041 | 1.4 | 3/3 |
| VA Run 17 | 10.1 | 24.2 | 0.085 | 0.103 | 2.1 | 3/3 |
| VA Run 13 | 6.5 | 15.0 | 0.142 | 0.093 | 1.3 | 2/3 |
| VA Run 14 | 3.3 | 16.7 | 0.119 | 0.072 | 0.5 | 0/3 |
aSampling time of each filter (10 minutes) divided by total run time. bFluorescence yield (observed/expected) for sampling run. cPredicted = TCID50 per ml * Total ml nebulized * Fractional sampling time per filter * Yield.
Figure 3PCR analysis of experimental contaminated air samples from VA Run 17 Lane 1: Marker; Lane 2:Nebulizer solution before run; Lane 3: Nebulizer solution after run; Lane 4: Filter without UV exposure; Lane 5: UV exposed filter; Lane 6: UV exposed filter; Lane 7: Filter without UV exposure; Lane 8: Spiked filter Lane 9: Filter without UV exposure; Lane 10: Blank filter; Lane 11: Positive control; Lane 12: Negative control.